Cargando…
First clinical application of a novel T1 mapping of the whole brain
BACKGROUND: The aim of this study was to evaluate the reproducibility and clinical value of the novel single-shot T1 mapping method for rapid and accurate multi-slice coverage of the whole brain, described by Wang et al. 2015. METHODS: At a field strength of 3 Tesla, T1 mappings of 139 patients (51...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626833/ https://www.ncbi.nlm.nih.gov/pubmed/35446175 http://dx.doi.org/10.1177/19714009221084244 |
_version_ | 1784822821845729280 |
---|---|
author | Müller, Sebastian Johannes Khadhraoui, Eya Voit, Dirk Riedel, Christian Heiner Frahm, Jens Ernst, Marielle |
author_facet | Müller, Sebastian Johannes Khadhraoui, Eya Voit, Dirk Riedel, Christian Heiner Frahm, Jens Ernst, Marielle |
author_sort | Müller, Sebastian Johannes |
collection | PubMed |
description | BACKGROUND: The aim of this study was to evaluate the reproducibility and clinical value of the novel single-shot T1 mapping method for rapid and accurate multi-slice coverage of the whole brain, described by Wang et al. 2015. METHODS: At a field strength of 3 Tesla, T1 mappings of 139 patients (51 of them without pathologic findings) and two repeats of five volunteers were performed at 0.5 mm in-plane resolution. Mean T1 values were determined in 18 manually segmented regions-of-interest without pathologic findings. Reproducibility of the repeated scans was calculated using mean coefficient of variations. Pathologies were grouped and separately evaluated. RESULTS: The mean age of the cohort was 49 (range 1–95 years). T1 relaxation times for ordinary brain and pathologies were in accordance with the literature values. Intra- and inter-subject reproducibility was excellent, and mean coefficient of variations were 2.4% and 3.8%, respectively. DISCUSSION: The novel rapid T1 mapping method is a reliable magnetic resonance imaging technique for identifying and quantifying normal brain structures and may thus serve as a basis for assessing pathologies. The fast and parallel online calculation enables a comfortable use in everyday clinical practice. We see a possible clinical value in a large spectrum of diseases, which should be investigated in further studies. |
format | Online Article Text |
id | pubmed-9626833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-96268332022-11-03 First clinical application of a novel T1 mapping of the whole brain Müller, Sebastian Johannes Khadhraoui, Eya Voit, Dirk Riedel, Christian Heiner Frahm, Jens Ernst, Marielle Neuroradiol J Original Articles BACKGROUND: The aim of this study was to evaluate the reproducibility and clinical value of the novel single-shot T1 mapping method for rapid and accurate multi-slice coverage of the whole brain, described by Wang et al. 2015. METHODS: At a field strength of 3 Tesla, T1 mappings of 139 patients (51 of them without pathologic findings) and two repeats of five volunteers were performed at 0.5 mm in-plane resolution. Mean T1 values were determined in 18 manually segmented regions-of-interest without pathologic findings. Reproducibility of the repeated scans was calculated using mean coefficient of variations. Pathologies were grouped and separately evaluated. RESULTS: The mean age of the cohort was 49 (range 1–95 years). T1 relaxation times for ordinary brain and pathologies were in accordance with the literature values. Intra- and inter-subject reproducibility was excellent, and mean coefficient of variations were 2.4% and 3.8%, respectively. DISCUSSION: The novel rapid T1 mapping method is a reliable magnetic resonance imaging technique for identifying and quantifying normal brain structures and may thus serve as a basis for assessing pathologies. The fast and parallel online calculation enables a comfortable use in everyday clinical practice. We see a possible clinical value in a large spectrum of diseases, which should be investigated in further studies. SAGE Publications 2022-04-21 2022-12 /pmc/articles/PMC9626833/ /pubmed/35446175 http://dx.doi.org/10.1177/19714009221084244 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Müller, Sebastian Johannes Khadhraoui, Eya Voit, Dirk Riedel, Christian Heiner Frahm, Jens Ernst, Marielle First clinical application of a novel T1 mapping of the whole brain |
title | First clinical application of a novel T1 mapping of the whole
brain |
title_full | First clinical application of a novel T1 mapping of the whole
brain |
title_fullStr | First clinical application of a novel T1 mapping of the whole
brain |
title_full_unstemmed | First clinical application of a novel T1 mapping of the whole
brain |
title_short | First clinical application of a novel T1 mapping of the whole
brain |
title_sort | first clinical application of a novel t1 mapping of the whole
brain |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626833/ https://www.ncbi.nlm.nih.gov/pubmed/35446175 http://dx.doi.org/10.1177/19714009221084244 |
work_keys_str_mv | AT mullersebastianjohannes firstclinicalapplicationofanovelt1mappingofthewholebrain AT khadhraouieya firstclinicalapplicationofanovelt1mappingofthewholebrain AT voitdirk firstclinicalapplicationofanovelt1mappingofthewholebrain AT riedelchristianheiner firstclinicalapplicationofanovelt1mappingofthewholebrain AT frahmjens firstclinicalapplicationofanovelt1mappingofthewholebrain AT ernstmarielle firstclinicalapplicationofanovelt1mappingofthewholebrain |